Clinical Trial Update: Cognitive Outcomes in Stable Renal Transplant Patients Switched FromTacrolimus to Envarsus XR™ [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating cognitive outcomes in stable renal transplant patients switched from tacrolimus to Envarsus XR.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant

Drugs mentioned

• Envarsus XR (Tacrolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Renal Transplant | Phase 4 | Status: ACTIVE_NOT_RECRUITING